GURUFOCUS.COM » STOCK LIST » Technology » Software » Glintt - Global Intelligent Technologies SA (XLIS:GLINT) » Definitions » Valuation Rank

Glintt - Global Intelligent Technologies (XLIS:GLINT) Valuation Rank


View and export this data going back to 1999. Start your Free Trial

What is Glintt - Global Intelligent Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Glintt - Global Intelligent Technologies Valuation Rank Related Terms

Thank you for viewing the detailed overview of Glintt - Global Intelligent Technologies's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Glintt - Global Intelligent Technologies (XLIS:GLINT) Business Description

Traded in Other Exchanges
Address
Beloura Office Park, Edificio 10, Quinta da Beloura, Sintra, PRT, 2710-693
Glintt - Global Intelligent Technologies SA along with its holding provides Information Technology and related consulting services. It offers business consulting, management of IT infrastructures and solutions, physical design & automation, software solution, and support services. The company serves healthcare, pharma, financial services, and public sector. It operates in Portugal, Spain, Angola, Brazil, the United Kingdom, and Ireland.